Cargando…
Tackling cisplatin resistance in ovarian cancer: what can we do?
Autor principal: | Perego, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992457/ https://www.ncbi.nlm.nih.gov/pubmed/35582376 http://dx.doi.org/10.20517/cdr.2021.59 |
Ejemplares similares
-
Tackling Resistance to Cancer Immunotherapy: What Do We Know?
por: Gondhowiardjo, Soehartati A., et al.
Publicado: (2020) -
We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020) -
Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022) -
Racism in science: what can we do about it?
Publicado: (2020) -
The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)